David P. Meeker, President and CEO of Rhythm Pharmaceuticals ($RYTM), sold about $2.8 million worth of company shares in two open market transactions over the last year. His most recent sale occurred on June 3, 2025. These sales rank 2,822nd among 11,678 individual insiders in our database, where the average is $8.6 million across 6.4 transactions per insider. Meeker made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | A | Stock Options (Right to Buy) | 107850 | $0.00 | 107,850.0000 | 64,984,361 | 9999.99% | 0.17% |
| Feb. 11, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | A | Restricted Stock Units | 71900 | $0.00 | 71,900.0000 | 64,984,361 | 9999.99% | 0.11% |
| Feb. 1, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | M | Restricted Stock Units | 21250 | $0.00 | 42,500.0000 | 64,984,361 | 33.33% | 0.03% |
| Feb. 1, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | M | Restricted Stock Units | 14125 | $0.00 | 14,125.0000 | 64,984,361 | 50.00% | 0.02% |
| Feb. 1, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | F | Common Stock | 31522 | $108.99 | 239,016.0000 | 64,984,361 | 11.65% | 0.05% |
| Feb. 1, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | M | Restricted Stock Units | 33338 | $0.00 | 100,012.0000 | 64,984,361 | 25.00% | 0.05% |
| Feb. 1, 2026 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | M | Common Stock | 68713 | $0.00 | 270,538.0000 | 64,984,361 | 34.05% | 0.11% |
| June 11, 2025 | Trevi Therapeutics, Inc. | $TRVI | Meeker David P | Not found | A | Nonstatutory Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 101,971,873 | 9999.99% | 0.04% |
| June 3, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | S | Common Stock | 274 | $65.60 | 201,825.0000 | 63,059,165 | 0.14% | 0.00% |
| June 3, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | M | Stock Option (Right to Buy) | 43620 | $0.00 | 0.0000 | 63,059,165 | 100.00% | 0.07% |
| June 3, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | M | Common Stock | 43620 | $4.59 | 245,445.0000 | 63,059,165 | 21.61% | 0.07% |
| June 3, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | S | Common Stock | 43346 | $65.04 | 202,099.0000 | 63,059,165 | 17.66% | 0.07% |
| Feb. 14, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | A | Stock Options (Right to Buy) | 200000 | $0.00 | 200,000.0000 | 60,995,204 | 9999.99% | 0.33% |
| Feb. 16, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | M | Restricted Stock Units | 21250 | $0.00 | 63,750.0000 | 60,995,204 | 25.00% | 0.03% |
| Feb. 16, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | M | Common Stock | 21250 | $0.00 | 211,177.0000 | 60,995,204 | 11.19% | 0.03% |
| Feb. 19, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | S | Common Stock | 9896 | $57.22 | 201,281.0000 | 60,995,204 | 4.69% | 0.02% |
| Feb. 14, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | A | Restricted Stock Units | 133350 | $0.00 | 133,350.0000 | 60,995,204 | 9999.99% | 0.22% |
| Feb. 1, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | M | Common Stock | 14125 | $0.00 | 194,205.0000 | 60,995,204 | 7.84% | 0.02% |
| Feb. 4, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | S | Common Stock | 4278 | $59.43 | 189,927.0000 | 60,995,204 | 2.20% | 0.01% |
| Feb. 1, 2025 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | M | Restricted Stock Units | 14125 | $0.00 | 28,250.0000 | 60,995,204 | 33.33% | 0.02% |
| Aug. 27, 2024 | Trevi Therapeutics, Inc. | $TRVI | Meeker David P | Not found | M | Common Stock | 4555 | $1.43 | 357,044.0000 | 99,033,373 | 1.29% | 0.00% |
| Aug. 27, 2024 | Trevi Therapeutics, Inc. | $TRVI | Meeker David P | Not found | M | Stock Option (right to buy) | 4555 | $0.00 | 0.0000 | 99,033,373 | 100.00% | 0.00% |
| Aug. 27, 2024 | Trevi Therapeutics, Inc. | $TRVI | Meeker David P | Not found | S | Common Stock | 4555 | $2.93 | 352,489.0000 | 99,033,373 | 1.28% | 0.00% |
| June 13, 2024 | Trevi Therapeutics, Inc. | $TRVI | Meeker David P | Not found | A | Nonstatutory Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 99,033,373 | 9999.99% | 0.03% |
| March 19, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | S | Common Stock | 45494 | $39.22 | 174,605.0000 | 57,673,128 | 20.67% | 0.08% |
| Feb. 16, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | A | Common Stock | 99000 | $0.00 | 220,099.0000 | 57,673,128 | 81.75% | 0.17% |
| Feb. 16, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | A | Stock Option (Right to Buy) | 259000 | $0.00 | 259,000.0000 | 57,673,128 | 9999.99% | 0.45% |
| Feb. 16, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | A | Restricted Stock Units | 85000 | $0.00 | 85,000.0000 | 57,673,128 | 9999.99% | 0.15% |
| Feb. 1, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | S | Common Stock | 4361 | $45.06 | 121,099.0000 | 57,673,128 | 3.48% | 0.01% |
| Feb. 1, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | M | Common Stock | 14125 | $0.00 | 125,460.0000 | 57,673,128 | 12.69% | 0.02% |
| Feb. 1, 2024 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | M | Restricted Stock Units | 14125 | $0.00 | 42,375.0000 | 57,673,128 | 25.00% | 0.02% |
| Feb. 1, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | A | Stock Option (Right to Buy) | 229600 | $0.00 | 229,600.0000 | 52,120,701 | 9999.99% | 0.44% |
| Feb. 1, 2023 | RHYTHM PHARMACEUTICALS, INC. | $RYTM | Meeker David P | President and CEO | A | Restricted Stock Units | 56500 | $0.00 | 56,500.0000 | 52,120,701 | 9999.99% | 0.11% |